Individuals enrolled in consumer-directed health plans (CDHPs) experiencing a COVID-19-like respiratory hospitalisation have significantly higher out-of-pocket (OOP) spending than individuals enrolled in traditional plans in the US.

This is the main finding of a study that examined OOP spending associated with respiratory hospitalisations for conditions similar to those caused by coronavirus disease 2019 (COVID-19) for commercially insured individuals aged \< 65 years using administrative claims data for the period from January 2016 to August 2019. OOP spending for CDHP enrollees was compared with that for individuals enrolled in traditional, low-deductible plans.

The analysis of data from 34 395 individuals showed that average OOP spending for respiratory hospitalisations was significantly higher among CDHP enrollees than among enrollees in traditional plans (\$US1961 vs \$1653; 2019 values). This difference was largest for those aged 0−21 years (\$2237 vs \$1685), decreasing with increasing age. The analysis also showed that the largest difference in OOP spending occurred for those hospitalised during the first quarter of the year (\$2578 vs \$1978). \"Financial strain associated with respiratory-related hospitalizations due to COVID-19 may fall disproportionately on CDHP enrollees,\" conclude the researchers. They suggest that \"self-insured employers that have not waived cost-sharing payments for hospitalizations related to COVID-19 should consider doing so; for those that do not, federal policymakers should consider waiving cost sharing for those in self-insured plans, as some in Congress are currently debating.\"
